Expasy logo

UniProtKB/Swiss-Prot variant pages

UniProtKB/Swiss-Prot P22830: Variant p.Phe260Leu

Ferrochelatase, mitochondrial
Gene: FECH
Feedback?
Variant information Variant position: help 260 The position of the amino-acid change on the UniProtKB canonical protein sequence.
Type of variant: help LP/P [Disclaimer] The variants are classified into three categories: LP/P, LB/B and US.
  • LP/P: likely pathogenic or pathogenic.
  • LB/B: likely benign or benign.
  • US: uncertain significance

Residue change: help From Phenylalanine (F) to Leucine (L) at position 260 (F260L, p.Phe260Leu). Indicates the amino acid change of the variant. The one-letter and three-letter codes for amino acids used in UniProtKB/Swiss-Prot are those adopted by the commission on Biochemical Nomenclature of the IUPAC-IUB.
Physico-chemical properties: help Change from large size and aromatic (F) to medium size and hydrophobic (L) The physico-chemical property of the reference and variant residues and the change implicated.
BLOSUM score: help 0 The score within a Blosum matrix for the corresponding wild-type to variant amino acid change. The log-odds score measures the logarithm for the ratio of the likelihood of two amino acids appearing by chance. The Blosum62 substitution matrix is used. This substitution matrix contains scores for all possible exchanges of one amino acid with another:
  • Lowest score: -4 (low probability of substitution).
  • Highest score: 11 (high probability of substitution).
More information can be found on the following page

Variant description: help In EPP1; enzyme retains 52% of activity. Any additional useful information about the variant.


Sequence information Variant position: help 260 The position of the amino-acid change on the UniProtKB canonical protein sequence.
Protein sequence length: help 423 The length of the canonical sequence.
Location on the sequence: help HILKELDHFPLEKRSEVVIL F SAHSLPMSVVNRGDPYPQEV The residue change on the sequence. Unless the variant is located at the beginning or at the end of the protein sequence, both residues upstream (20) and downstream (20) of the variant will be shown.
Residue conservation: help The multiple alignment of the region surrounding the variant against various orthologous sequences.
Human                         HILKELDHFPLEKR---------------SEVVILFSAHSLPMSVVNRGDPYPQEV

Chimpanzee                    HILKELDHFPLEKR---------------SEVVILFSAHSL

Mouse                         HILKELNHFPEEKR---------------SEVVILFSAHSL

Bovine                        HILKELDHFPPEKR---------------REVVILFSAHSL

Chicken                       HIQKELDLFPPDKR---------------KDVVILFSAHSL

Xenopus laevis                HIQKELNMFPADKR---------------GEVVILFSAHSL

Drosophila                    RIRDELAKFVETKR---------------NDVVILFTAHSL

Slime mold                    KIKKAYNQFNSKLRELDIDDVDANNNNNNNKPVLVFSAHSL

Baker's yeast                 NITKKLQEFPQPVR---------------DKVVLLFSAHSL

Fission yeast                 NIEETLKTYPEDVR---------------DDVVIVFSAHSL

Sequence annotation in neighborhood: help The regions or sites of interest surrounding the variant. In general the features listed are posttranslational modifications, binding sites, enzyme active sites, local secondary structure or other characteristics reported in the cited references. The "Sequence annotation in neighborhood" lines have a fixed format:
  • Type: the type of sequence feature.
  • Positions: endpoints of the sequence feature.
  • Description: contains additional information about the feature.
TypePositionsDescription
Chain 55 – 423 Ferrochelatase, mitochondrial
Beta strand 257 – 263



Literature citations
Autosomal recessive erythropoietic protoporphyria in the United Kingdom: prevalence and relationship to liver disease.
Whatley S.D.; Mason N.G.; Khan M.; Zamiri M.; Badminton M.N.; Missaoui W.N.; Dailey T.A.; Dailey H.A.; Douglas W.S.; Wainwright N.J.; Elder G.H.;
J. Med. Genet. 41:E105-E105(2004)
Cited for: VARIANTS EPP1 LEU-139; TYR-236; LEU-260 AND ASN-379; CHARACTERIZATION OF VARIANTS EPP1 LEU-139; TYR-236; LEU-260 AND ASN-379;
Disclaimer: Any medical or genetic information present in this entry is provided for research, educational and informational purposes only. They are not in any way intended to be used as a substitute for professional medical advice, diagnostic, treatment or care.